Skip to Content

ELISA PRKCH anti-

https://www.anagnostics.com/web/image/product.template/100464/image_1920?unique=6afd206
Quantity :50µg Clone Number: Aliases:KPCL_ antibody; MGC 5363 antibody; MGC26269 antibody; MGC5363 antibody; nPKC eta antibody; nPKC-eta antibody; PKC h antibody; PKC L antibody; PKC-L antibody; PKCh antibody; PKCL antibody; Prkch antibody; PRKCL antibody; Protein kinase C eta antibody; Protein kinase C eta type antibody Product Type:Polyclonal Antibody Immunogen Species:Homo sapiens () UniProt ID:P24723 Immunogen:Recombinant Protein kinase C eta type protein (1-678AA) Raised in:Rabbit Reactivity:, Mouse, Rat Tested Applications:ELISA, WB, IHC; Recommended dilution: WB:1:500-1:5000, IHC:1:500-1:1000 Background:Calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that is involved in the regµLation of cell differentiation in keratinocytes and pre-B cell receptor, mediates regµLation of epithelial tight junction integrity and foam cell formation, and is required for glioblastoma proliferation and apoptosis prevention in MCF-7 cells. In keratinocytes, binds and activates the tyrosine kinase FYN, which in turn blocks epidermal growth factor receptor (EGFR) signaling and leads to keratinocyte growth arrest and differentiation. Associates with the cyclin CCNE1-CDK2-CDKN1B complex and inhibits CDK2 kinase activity, leading to RB1 dephosphorylation and thereby G1 arrest in keratinocytes. In association with RALA activates actin depolymerization, which is necessary for keratinocyte differentiation. In the pre-B cell receptor signaling, functions downstream of BLNK by up-regµLating IRF4, which in turn activates L chain gene rearrangement. RegµLates epithelial tight junctions (TJs) by phosphorylating occludin (OCLN) on threonine residues, which is necessary for the assembly and maintenance of TJs. In association with PLD2 and via TLR4 signaling, is involved in lipopolysaccharide (LPS)-induced RGS2 down-regµLation and foam cell formation. Upon PMA stimµLation, mediates glioblastoma cell proliferation by activating the mTOR pathway, the PI3K/AKT pathway and the ERK1-dependent phosphorylation of ELK1. Involved in the protection of glioblastoma cells from irradiation-induced apoptosis by preventing caspase-9 activation. In camptothecin-treated MCF-7 cells, regµLates NF-kappa-B upstream signaling by activating IKBKB, and confers protection against DNA damage-induced apoptosis. Promotes oncogenic functions of ATF2 in the nucleus while blocking its apoptotic function at mitochondria. Phosphorylates ATF2 which promotes its nuclear retention and transcriptional activity and negatively regµLates its mitochondrial localization. Clonality:Polyclonal Isotype:IgG Purification Method:>95%, Protein G purified Conjµgate:Non-conjµgated Buffer:Preservative: 0.03% Proclin 300 Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 Form:Liquid Stroage:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze. Target Names:PRKCH Research Areas:Metabolism; Signal transduction

431.60 € 431.6 EUR 431.60 €

431.60 €

Not Available For Sale

This combination does not exist.

Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days